title: Major cardiovascular events associated with anti-IL 12/23 agents: a tale of two meta-analyses.
authors.affiliation: Department of Dermatology, Boston University, Boston, Massachusetts, USA. erica.dommasch@bmc.org
authors.forename: Erica D
authors.initials: ED
authors.lastname: Dommasch
authors.forename: Andrea B
authors.initials: AB
authors.lastname: Troxel
authors.forename: Joel M
authors.initials: JM
authors.lastname: Gelfand
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D006801:Humans; D018664:Interleukin-12 / Q000037:antagonists & inhibitors; D053759:Interleukin-23 / Q000037:antagonists & inhibitors; D011565:Psoriasis / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D000069549:Ustekinumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D053759:Interleukin-23; D018664:Interleukin-12; C544528:briakinumab; D000069549:Ustekinumab